Dermapharm Holding SE buy Saftman
Summary
This prediction ended on 15.09.22 with a price of €41.68. The BUY prediction by Saftman for Dermapharm Holding SE performed very badly with a performance of -50.67%. Saftman has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Dermapharm Holding SE | 6.518% | 6.518% | -24.617% |
iShares Core DAX® | -0.922% | -1.993% | 13.399% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% |
Comments by Saftman for this prediction
In the thread Dermapharm Holding SE diskutieren
In the thread Trading Dermapharm Holding SE